A prognostic index model for predicting overall survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate after docetaxelK.N. Chi, Howard I. Scher, Charles J. Ryan et al.|Annals of Oncology|2015Cited by 170